| AAOMS | American association of oral and maxillofacial surgeons; |
| APC | Autologous platelet concentrate; |
| ASBMR | American society for bone and mineral research; |
| BP | Bisphosphonate; |
| BRONJ | Biphosphonate-related osteonecrosis of the jaw; |
| CI | Confidential interval; |
| CT | Computed tomography; |
| CTX | Collagen type I c-telopeptide; |
| Er:YAG | Erbium YAG; |
| IDT | Invasive dental treatment; |
| MMP9 | Matrix metallopeptidase 9; |
| MRI | Magnetic resonance imaging; |
| MRONJ | Medication-related osteonecrosis of the jaw; |
| mTOR | Mammalian Target of Rapamycin; |
| PD | Periodontal disease; |
| RANKL | Receptor activator for nuclear factor κB ligand; |
| VEGF | Vascular endothelial growth factor. |